There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

RARE Act of 2018
Rare disease Advancement, Research, and Education Act of 2018

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To expand and improve the programs and activities of the Department of Health and Human Services for awareness, education, research, surveillance, diagnosis, and treatment concerning rare diseases and conditions.


Actions Overview (1)

Date
02/27/2018Introduced in House

All Actions (3)

Date
03/02/2018Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
02/27/2018Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
02/27/2018Introduced in House
Action By: House of Representatives

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce02/27/2018 Referred to
House Energy and Commerce Subcommittee on Health03/02/2018 Referred to

No related bill information was received for H.R.5115.


Subjects (1)


Latest Summary (1)

There is one summary for H.R.5115. View summaries

Shown Here:
Introduced in House (02/27/2018)

Rare disease Advancement, Research, and Education Act of 2018 or the RARE Act of 2018

This bill reauthorizes through FY2023 the Office of Rare Diseases in the National Institutes of Health.

The bill requires (1) the Centers for Disease Control and Prevention to expand infrastructure and activities to track the epidemiology of rare diseases and conditions and to incorporate this information into a National Rare Disease or Condition Surveillance System, and (2) the Agency for Healthcare Research and Quality to expand its activities to increase providers' awareness of rare diseases and conditions.